Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Smithfield Foods (SFD) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Smithfield Foods (SFD) over the last 11 years, with Q3 2025 value amounting to $773.0 million.

  • Smithfield Foods' Cash & Equivalents rose 17805.76% to $773.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $773.0 million, marking a year-over-year increase of 17805.76%. This contributed to the annual value of $943.0 million for FY2024, which is 3726.35% up from last year.
  • Per Smithfield Foods' latest filing, its Cash & Equivalents stood at $773.0 million for Q3 2025, which was up 17805.76% from $928.0 million recorded in Q2 2025.
  • Smithfield Foods' 5-year Cash & Equivalents high stood at $943.0 million for Q4 2024, and its period low was $204.0 million during Q1 2024.
  • Over the past 3 years, Smithfield Foods' median Cash & Equivalents value was $730.0 million (recorded in 2023), while the average stood at $619.5 million.
  • Per our database at Business Quant, Smithfield Foods' Cash & Equivalents skyrocketed by 3726.35% in 2024 and then surged by 35490.2% in 2025.
  • Over the past 3 years, Smithfield Foods' Cash & Equivalents (Quarter) stood at $687.0 million in 2023, then soared by 37.26% to $943.0 million in 2024, then fell by 18.03% to $773.0 million in 2025.
  • Its Cash & Equivalents was $773.0 million in Q3 2025, compared to $928.0 million in Q2 2025 and $928.0 million in Q1 2025.